Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Clinical trial NCT03663725 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03663725
- Sponsor
- Centre Oscar Lambret
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2027-06-01
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.